Leadership Team

Kristie Grebe, PhD
Chief Scientific Officer

Kristie brings over 20 years of experience in immunological, clinical and translational research. Throughout her career she has led and supported translational teams from discovery through phase 3b/IV across a range of small molecule and biologic programs for gastroenterology, rheumatology and dermatology indications including SKYRIZI®(risankizumab-rzaa), RINVOQ® (upadacitinib) and HUMIRA®(adalimumab).

Most recently Kristie served as Chief Scientific Officer at Anokion where she led both clinical and preclinical development for an immune tolerance platform. Prior to joining Anokion, Kristie spent more than a decade in positions of increasing responsibility at Abbvie leading clinical translational strategy for multiple programs in the Immunology pipeline.

Kristie completed her postdoctoral fellowship in the Laboratory of Viral Disease at the National Institutes of Health. Kristie holds a Ph.D. in Microbiology and Immunology from the University of Colorado Health Science Center and a B.S. in Microbiology and Cell Science from the University of Florida.